Skip to main content
. 2024 Jun 20;14(6):616. doi: 10.3390/brainsci14060616

Table 1.

General characteristics of the study sample.

AIS Group HS Group p
(n = 200) (n = 200)
Demographics
Age (years) 73 (61–81) 58 (50–67) <0.001
Sex (male) 120 (60) 116 (58) 0.760
Comorbidities
Diabetes 48 (24) 15 (7.5) <0.001
Hypertension 156 (78) 54 (27) <0.001
Dyslipidemia 86 (43) 45 (22.5) <0.001
Previous stroke 42 (21) 4 (2) <0.001
Atrial fibrillation 50 (25) 8 (4) <0.001
Cancer 32 (16) 28 (14) 0.675
Hepatopathy 7 (3.5) 7 (3.5) 1.000
Respiratory disease 29 (14.5) 10 (5) 0.002
Obesity 33 (16.5) 41 (20.5) 0.367
Pharmacological data
Beta blockers 87 (43.5) 22 (11) <0.001
Alpha blockers 37 (18.5) 9 (4.5) <0.001
ACE inhibitors 103 (51.5) 30 (15) <0.001
Sartans 48 (24) 22 (11) 0.001
Calcium channel blockers 74 (37) 17 (8.5) <0.001
Antidepressants 12 (6) 5 (2.5) 0.135

Abbreviations: AIS, acute ischemic stroke; HS, healthy subjects Qualitative variables are expressed as absolute and relative percentage frequencies; quantitative data are presented as median and interquartile ranges.